Table Of Contents

1. Introduction 29
1.1. Objectives Of The Study 29
1.2. Market Definition 29
1.3. Overview Of Asia-Pacific Infertility Testing Market 29
1.4. Currency And Pricing 30
1.5. Limitation 30
1.6. Markets Covered 31
2. Market Segmentation 33
2.1. Markets Covered 33
2.2. Geographic Scope 34
2.3. Years Considered For The Study 35
2.4. Currency And Pricing 35
2.5. Research Methodology 36
2.6. Primary Interviews With Key Opinion Leaders 40
2.7. Secondary Sources 41
2.8. Assumptions 41
3. Market Overview 42
3.1. Drivers 44
3.1.1. Significant Decline In Fertility Rates 44
3.1.2. Rising Public Awareness Among The Female Population 45
3.1.3. Increasing Number Of Gynaecological Disorders 45
3.1.4. Technological Advancements And Innovative Testing Products 45
3.2. Restraints 46
3.2.1. High Cost Of Ovulation Testing 46
3.2.2. Accuracy Issues With Testing Kits 46
?
3.3. Opportunities 47
3.3.1. Reduction In The Cost Of Infertility Treatment 47
3.3.2. Emergence Of Combination Testing Kits 47
3.4. Challenges 47
3.4.1. Stringent Regulatory Scenario 47
3.4.2. Infertility Considered As Social Taboo 47
4. Executive Summary 48
5. Premium Insights 50
6. Asia-Pacific Infertility Testing Market, By Type 53
6.1. Overview 54
6.2. Female Infertility Testing 56
6.2.1. Ovulation Testing 57
6.2.2. Hysterosalpingography 57
6.2.3. Laparoscopy 57
6.2.4. Transvaginal Ultrasound 58
6.2.5. Ovarian Reserve Testing 58
6.2.6. Hormone Testing 58
6.2.7. Others 58
6.3. Male Infertility Testing 59
6.3.1. Dna Fragmentation 60
6.3.2. Oxidative Stress Analysis 60
6.3.3. Sperm Penetration Assay 60
6.3.4. Computer Aided Semen Analysis 61
6.3.5. Sperm Agglutination Assay 61
6.3.6. Microscopic Examination 61
6.3.7. Others 61
?
7. Asia-Pacific Infertility Testing Market, By Test Kits 62
7.1. Overview 63
7.2. Follicular Stimulating Hormone (Fsh) Urine Test Kits 65
7.3. Luteinizing Hormone (Lh) Urine Test Kits 66
7.4. Human Chorionic Gonadotropin (Hcg) Hormone
Blood Test Kits 67
7.5. Other Test Kits 68
8. Asia-Pacific Infertility Testing Market, By Prescription Mode 69
8.1. Overview 70
8.2. Prescription Based 72
8.3. Over The Counter (Otc) Based 73
9. Asia-Pacific Infertility Testing Market, By Distribution Channel 74
9.1. Overview 75
9.2. Hospitals Pharmacies 77
9.3. Online Pharmacies 78
9.4. Pharmacies & Drug Stores 79
10. Asia-Pacific Infertility Testing Market, By End Users 80
10.1. Overview 81
10.2. Fertility Centers 83
10.3. Hospitals And Clinics 84
10.4. Research Institutes 85
10.5. Cryobanks 86
11. Asia-Pacific Infertility Testing Market, By Geography 87
11.1. Asia-Pacific 174
11.1.1. Japan 185
11.1.2. China 189
11.1.3. India 193
11.1.4. South Korea 197
11.1.5. Australia 201
11.1.6. Singapore 206
11.1.7. Thailand 211
11.1.8. Malaysia 216
11.1.9. Indonesia 221
11.1.10. Philippines 226
11.1.11. Rest Of Asia Pacific 231
12. Asia-Pacific Infertility Testing Market, Company Landscape 266
12.1. Company Share Analysis; Asia-Pacific 269
13. Company Profiles 270
13.1. Babystart Ltd 270
13.1.1. Company Overview 270
13.1.2. Babystart Ltd; Company Snapshot 270
13.1.3. Product Portfolio 271
13.1.4. Recent Developments 271
13.2. Biozhena Corporation 272
13.2.1. Company Overview 272
13.2.2. Biozhena Corporation;Company Snapshot 272
13.2.3. Product Portfolio 272
13.2.4. Recent Developments 272
13.3. Quidel Corporation 273
13.3.1. Company Overview 273
13.3.2. Quidel Corporation; Revenue Analysis 273
13.3.3. Product Portfolio 274
13.3.4. Recent Developments 274
13.4. Alere Inc. 275
13.4.1. Company Overview 275
13.4.2. Alere Inc.; Revenue Analysis 275
13.4.3. Product Portfolio 276
13.4.4. Recent Developments 276
13.5. Biom?rieux 277
13.5.1. Company Overview 277
13.5.2. Biom?rieux; Revenue Analysis 277
13.5.3. Product Portfolio 278
13.5.4. Recent Developments 278
13.6. Spd Swiss Precision Diagnostics Gmbh 279
13.6.1. Company Overview 279
13.6.2. Spd Swiss Precision Diagnostics Gmbh; Company Snapshot 279
13.6.3. Product Portfolio 280
13.6.4. Recent Developments 280
13.7. Procter & Gamble 281
13.7.1. Company Overview 281
13.7.2. Procter & Gamble; Revenue Analysis 281
13.7.3. Product Portfolio 282
13.7.4. Recent Developments 282
13.8. Scsa Diagnostics, Inc. 283
13.8.1. Company Overview 283
13.8.2. Scsa Diagnostics, Inc; Company Snapshot 283
13.8.3. Product Portfolio 283
13.8.4. Recent Developments 283
13.9. Andrology Solutions 284
13.9.1. Company Overview 284
13.9.2. Andrology Solutions; Company Snapshot 284
13.9.3. Product Portfolio 285
13.9.4. Recent Developments 285
?
13.10. Atlas Medical Uk 286
13.10.1. Company Overview 286
13.10.2. Atlas Medical Uk; Company Snapshot 286
13.10.3. Product Portfolio 286
13.10.4. Recent Developments 286
13.11. Halotech Dna 287
13.11.1. Company Overview 287
13.11.2. Halotech Dna; Company Snapshot 287
13.11.3. Product Portfolio 288
13.11.4. Recent Developments 288
13.12. Sa Scientific 289
13.12.1. Company Overview 289
13.12.2. Sa Scientific; Company Snapshot 289
13.12.3. Product Portfolio 289
13.12.4. Recent Developments 289
13.13. Gem Medic Technology Co.,Ltd 290
13.13.1. Company Overview 290
13.13.2. Gem Medic Technology Co., Ltd; Company Snapshot 290
13.13.3. Product Portfolio 291
13.13.4. Recent Developments 292
13.14. Merck Kgaa 293
13.14.1. Company Overview 293
13.14.2. Merck Kgaa; Revenue Analysis 293
13.14.3. Product Portfolio 294
13.14.4. Recent Developments 294
14. Related Reports 295